Piergiacomo Di Gennaro

Mr. Piergiacomo Di Gennaro

Medical statistic unit, University of Campania "Luigi Vanvitelli", Naples, Campania, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2022 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
MCMarco Cascella
Marco Cascella
FMFederica Monaco
Federica Monaco
DNDavide Nocerino
Davide Nocerino
ECElisabetta Chinè
Elisabetta Chinè
RCRoberta Carpenedo
Roberta Carpenedo
ACArturo Cuomo
Arturo Cuomo

18 July 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Giuseppe PorcielloGiuseppe Porciello
Giuseppe Porciello
SCSergio Coluccia
Sergio Coluccia
SVSara Vitale
Sara Vitale
EPElvira Palumbo
Elvira Palumbo
ALAssunta Luongo
Assunta Luongo
TGthe DEDiCa Study Group
the DEDiCa Study Group
Health-related quality of life (HRQoL) represents one of the most concerning aspects for cancer patients. The Healthy Eating Index (HEI) is an a priori diet quality index directly associated with health outcomes and HRQoL in cancer survivors in North American populations. We evaluated, in a Mediterranean population, the baseline associations between HEI-2015 and HRQoL in 492 women with breast cancer recruited in a DEDiCa lifestyle trial. Dietary data were obtained from 7-day food records; HRQoL was assessed through the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ C30) and the C30 Summary Score (SumSc). Analysis of variance and multivariable linear and log-gamma regression models were performed. Mean and standard deviation for HEI-2015 score was 68.8 ± 11.2; SumSc was 81.5 ± 12.9. Women with lower HEI-2015 score had higher BMI, were more frequently exposed to tobacco smoke and had fewer years of education. Patients with a HEI-2015 score greater than 68.7 (median value) showed a significant increase in SumSc of 4% (p = 0.02). HEI-2015 components also associated with SumSc were beans and greens (β = 1.04; p = 0.02). Weak associations were found for total vegetables and saturated fats. Higher diet quality in breast cancer survivors was associated with higher overall HRQoL in this cross-sectional analysis.

1 September 2024 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
Sabrina BimonteSabrina Bimonte
Sabrina Bimonte
Piergiacomo Di GennaroPiergiacomo Di Gennaro
Piergiacomo Di Gennaro
ACAnna Crispo
Anna Crispo
SCSergio Coluccia
Sergio Coluccia
ALAssunta Luongo
Assunta Luongo
ACArturo Cuomo
Arturo Cuomo
Purpose: Breakthrough cancer pain (BTcP) is a temporary exacerbation of pain that “breaks through” a phase of adequate pain control by an opioid-based therapy. The non-predictable BTcP (NP-BTcP) subtype occurs in the absence of any specific activity. Evidence showed that gender differences exist in pain response sensitivity and clinical pain risk. This analysis aimed to signify the gender differences for the NP-BTcP phenomenon. Patients and Methods: This is a secondary analysis of the Italian Oncologic Pain multiSetting-Multicentric Survey (IOPS-MS), the largest study on BTcP. The subset of NP-BTcP cases for non-gender-specific cancer was considered. Univariable and multivariate analyses were conducted to identify gender differences for the NP-BTcP profile about its intensity, number of episodes per day, and type. A metastatic status-stratified analysis was performed to compare gender with the main clinical variables among the population with NP-BTcP. Results: Males exhibited a higher occurrence of BTcP in the thorax region compared to females (15% vs 11%, respectively, p = 0.03). Males also had a higher onset of BTcP, a higher BTcP therapy dosage (33% vs 28%, p = 0.04, mean: 201 vs 186, p = 0.02) and a lower Karnofsky score (mean: 46.9 vs 49.2, p = 0.03) compared to females. Similar gender differences were found for metastatic patients in the BTcP site (14% vs 8.5%, respectively; p = 0.01), peak onset (33% vs 27%, p = 0.02), BTcP therapy dosage (199 vs 185, p=0.04), and Karnofsky score (mean 47.5 vs 50.4, p = 0.009). Phenotype 2 was more characterized by non-metastatic males (41% vs 23%, p = 0.020) while non-metastatic females presence was predominant among others. Conclusion: In this study, gender differences according to site, onset and dosage of BTcP were found. The phenotype characterization of BTcP needs to be further investigated for a possible useful function in the management of cancer-related pain in non-metastatic patients.

19 October 2023 in BMC Cancer
Verified
Journal Article
Open access
PDF file
AOAlessandro Ottaiano
Alessandro Ottaiano
Antonella De LucaAntonella De Luca
Antonella De Luca
MSMariachiara Santorsola
Mariachiara Santorsola
GSGiosuè Scognamiglio
Giosuè Scognamiglio
Annabella Di MauroAnnabella Di Mauro
Annabella Di Mauro
NNNicola Normanno
Nicola Normanno
Metastatic disease in tumors originating from the gastrointestinal tract can exhibit varying degrees of tumor burden at presentation. Some patients follow a less aggressive disease course, characterized by a limited number of metastatic sites, referred to as “oligo-metastatic disease” (OMD). The precise biological characteristics that define the oligometastatic behavior remain uncertain. In this study, we present a protocol designed to prospectively identify OMD, with the aim of proposing novel therapeutic approaches and monitoring strategies. The PREDICTION study is a monocentric, prospective, observational investigation. Enrolled patients will receive standard treatment, while translational activities will involve analysis of the tumor microenvironment and genomic profiling using immunohistochemistry and next-generation sequencing, respectively. The first primary objective (descriptive) is to determine the prevalence of biological characteristics in OMD derived from gastrointestinal tract neoplasms, including high genetic concordance between primary tumors and metastases, a significant infiltration of T lymphocytes, and the absence of clonal evolution favoring specific driver genes (KRAS and PIK3CA). The second co-primary objective (analytic) is to identify a prognostic score for true OMD, with a primary focus on metastatic colorectal cancer. The score will comprise genetic concordance (> 80%), high T-lymphocyte infiltration, and the absence of clonal evolution favoring driver genes. It is hypothesized that patients with true OMD (score 3+) will have a lower rate of progression/recurrence within one year (20%) compared to those with false OMD (80%). The endpoint of the co-primary objective is the rate of recurrence/progression at one year. Considering a reasonable probability (60%) of the three factors occurring simultaneously in true OMD (score 3+), using a significance level of α = 0.05 and a test power of 90%, the study requires a minimum enrollment of 32 patients. Few studies have explored the precise genetic and biological features of OMD thus far. In clinical settings, the diagnosis of OMD is typically made retrospectively, as some patients who undergo intensive treatment for oligometastases develop polymetastatic diseases within a year, while others do not experience disease progression (true OMD). In the coming years, the identification of true OMD will allow us to employ more personalized and comprehensive strategies in cancer treatment. ClinicalTrials.gov ID NCT05806151.

20 January 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
ACAnna Crispo
Anna Crispo
Piergiacomo Di GennaroPiergiacomo Di Gennaro
Piergiacomo Di Gennaro
SCSergio Coluccia
Sergio Coluccia
Sara GandiniSara Gandini
Sara Gandini
CMConcetta Montagnese
Concetta Montagnese
ECEgidio Celentano
Egidio Celentano
Background: From the beginning of 2020, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) quickly spread worldwide, becoming the main problem for the healthcare systems. Healthcare workers (HCWs) are at higher risk of infection and can be a dangerous vehicle for the spread of the virus. Furthermore, cancer patients (CPs) are a vulnerable population, with an increased risk of developing severe and lethal forms of Coronavirus Disease 19 (COVID-19). Therefore, at the National Cancer Institute of Naples, where only cancer patients are treated, a surveillance program aimed to prevent the hospital access of SARS-CoV-2 positive subjects (HCWs and CPs) was implemented. The study aims to describe the results of the monitoring activity for the SARS-CoV-2 spread among HCWs and CPs, from March 2020 to March 2021. Methods: This surveillance program included a periodic sampling through nasopharyngeal molecular swabs for SARS-CoV-2 (Real-Time Polymerase Chain Reaction, RT-PCR). CPs were submitted to the molecular test at least 48 h before hospital admission. Survival analysis and multiple logistic regression models were performed among HCWs and CPs to assess the main SARS-CoV-2 risk factors. Results: The percentages of HCWs tested with RT-PCR for the detection of SARS-CoV-2, according to the first and the second wave, were 79.7% and 91.7%, respectively, while the percentages for the CPs were 24.6% and 39.6%. SARS-CoV-2 was detected in 20 (1.7%) HCWs of the 1204 subjects tested during the first wave, and in 127 (9.2%) of 1385 subjects tested in the second wave (p < 0.001); among CPs, the prevalence of patients tested varied from 100 (4.6%) during the first wave to 168 (4.9%) during the second wave (p = 0.8). The multivariate logistic analysis provided a significant OR for nurses (OR = 2.24, 95% CI 1.23–4.08, p < 0.001) compared to research, administrative staff, and other job titles. Conclusions: Our findings show that the positivity rate between the two waves in the HCWs increased over time but not in the CPs; therefore, the importance of adopting stringent measures to contain the shock wave of SARS-CoV-2 infection in the hospital setting was essential. Among HCWs, nurses are more exposed to contagion and patients who needed continuity in oncological care for diseases other than COVID-19, such as suspected cancer.

22 September 2026 in Epidemiology, Biostatistics, and Public Health
Verified
Journal Article
Open access
PDF file
ASAnnafrancesca Smimmo
Annafrancesca Smimmo
FNFederica Nobile
Federica Nobile
PSPaola Schiattarella
Paola Schiattarella
TSTeresa Speranza
Teresa Speranza
Piergiacomo Di GennaroPiergiacomo Di Gennaro
Piergiacomo Di Gennaro
PCPaolo Chiodini
Paolo Chiodini
Introduction In health impact assessments (HIAs) of air pollution, a crucial issue is the correct specification of the concentration-response function (CRF) between exposure and outcome. Traditional approaches often assume a linear relationship, with the risk of introducing bias when the association is actually non-linear. In this context, Shape Constrained Health Impact Functions (SCHIF) represent a methodological advancement developed specifically for HIA. They allow flexible curves that are consistent with biological plausibility constraints to be modelled, while at the same time they estimate a single effect coefficient, since non-linearity is incorporated into the transformation of exposure in the risk function. SCHIF returns three estimates of the CRF from the optimal model, an ensemble of the best three models, and an ensemble of all estimated models. Simulation studies show that SCHIF better describe the association between PM2.5 and the outcome compared with linear models, but this has not yet been verified using real data. Objectives To evaluate, in a real cohort, the methodological robustness of the estimated CRF between chronic exposure to fine particulate matter (PM2.5) and non-accidental mortality obtained with the optimal SCHIF model; to compare the estimates with those obtained from Cox models with exposure specified as a linear term or by natural splines (NS). Methods The administrative cohort of residents (30+ years) in Rome on 09/10/2011 (2011 Census) was analysed, with follow-up to 31/12/2019. The following were estimated: (i) a Cox model with a linear term for PM2.5 (L), (ii) a Cox model with NS with 3 knots (S), and (iii) the SCHIF model, adjusted for individual- and area-level variables. The Bayesian Information Criterion (BIC) was used for model selection. Results All analytical approaches highlight the presence of a significant effect of PM2.5 exposure on the outcome. In L, the estimated exposure effect is β=0.012 (SE=0.029). However, the comparison with model S is statistically significant, indicating that the association is not adequately described by a linear relationship. In model S, the first spline term is significant (β=0.023; SE=0.009), whereas the additional non-linear terms are not. The optimal SCHIF model identifies a non-linear relationship, with deviation from linearity at the lowest PM2.5 levels, with an estimated coefficient of β(z)=0.140 (SE=0.032)×ω(z|min(z), 0.1)×log(1+z).In the comparison between models, the minimum BIC is observed for the SCHIF model, supporting a better fit to the data. Conclusions The SCHIF model shows the best fit and is confirmed as a promising approach for estimating more realistic and robust CRFs, useful in health impact assessments. Acknowledgments Project carried out with the technical and financial support of the Ministry of Health - PNC PREV-A-2022-12376.